GlassScriptPhysician profile
Allen Jetmore
NPI 1093725111
$1,860.17
in general payments reported to CMS, 2019-2025
15 companies · $367 in 2025
The $367 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $233 · 2020: $145 · 2021: $528 · 2022: $153 · 2023: $149 · 2024: $286 · 2025: $367.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $802.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $801.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $458.63 | 2019-2025 | Plenvu, Xifaxan |
| Organogenesis INC. | $207.83 | 2021-2024 | |
| Medtronic, INC. | $192.88 | 2025 | Interstim |
| Smith+Nephew, INC. | $182.69 | 2019-2022 | |
| Convatec INC. | $146.41 | 2024 | |
| Baudax Bio INC. | $142.88 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $128.19 | 2020-2025 | Rebyota, Clenpiq |
| Integra Lifesciences Corporation | $116.14 | 2020-2025 | Tcc-Ez |
| Braintree Laboratories, INC. | $80.46 | 2021 | |
| Lifenet Health | $39.17 | 2023-2024 | Theragenesis Wound Matrix |
| Vertex Pharmaceuticals Incorporated | $37.04 | 2025 | |
| Abbott Laboratories | $33.90 | 2022 | |
| Acera Surgical, INC. | $33.33 | 2021 | |
| Hydrofera LLC | $30.56 | 2023 | Hydrofera Blue |
| Misonix INC | $30.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allen Jetmore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.